Bio-Gene Technology Limited

ASX:BGT Stock Report

Market Cap: AU$7.7m

Bio-Gene Technology Management

Management criteria checks 1/4

Bio-Gene Technology's CEO is Tim Grogan, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is A$285.63K, comprised of 90.4% salary and 9.6% bonuses, including company stock and options. directly owns 0.03% of the company’s shares, worth A$2.26K. The average tenure of the management team and the board of directors is 1.3 years and 1.6 years respectively.

Key information

Tim Grogan

Chief executive officer

AU$285.6k

Total compensation

CEO salary percentage90.4%
CEO tenure1.3yrs
CEO ownership0.03%
Management average tenure1.3yrs
Board average tenure1.6yrs

Recent management updates

Recent updates

We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Feb 22
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Oct 25
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Jun 20
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

Apr 28
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Jan 11
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

CEO Compensation Analysis

How has Tim Grogan's remuneration changed compared to Bio-Gene Technology's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$286kAU$258k

-AU$2m

Compensation vs Market: Tim's total compensation ($USD185.62K) is below average for companies of similar size in the Australian market ($USD297.98K).

Compensation vs Earnings: Insufficient data to compare Tim's compensation with company performance.


CEO

Tim Grogan

1.3yrs

Tenure

AU$285,626

Compensation

Mr. Timothy Owen Grogan, LLB, B.Sc., also known as Tim, serves as Managing Director, Chief Executive Officer & Director of Bio-Gene Technology Limited since August 28, 2023. He serves as a Director of Cons...


Leadership Team

NamePositionTenureCompensationOwnership
Timothy Grogan
MD, CEO & Director1.3yrsAU$285.63k0.030%
A$ 2.3k
Edmond Tern
CFO & Company Secretaryless than a yearAU$125.43kno data
Peter May
Executive Director of Research & Development and Executive Director6.8yrsAU$238.43k0.91%
A$ 70.0k

1.3yrs

Average Tenure

Experienced Management: BGT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Timothy Grogan
MD, CEO & Director1.3yrsAU$285.63k0.030%
A$ 2.3k
Peter May
Executive Director of Research & Development and Executive Director9.5yrsAU$238.43k0.91%
A$ 70.0k
Douglas Rathbone
Adviser to the Board6.9yrsno datano data
Peter Beetham
Member of Scientific Advisory Board1.6yrsAU$45.50k0%
A$ 0
Andrew Guthrie
Non-Executive Director3.6yrsAU$59.77k0.13%
A$ 10.1k
Catherine Hill
Member of the Scientific Advisory Board6.8yrsno datano data
Neil Anderson
Member of Scientific Advisory Boardno datano datano data
Huong Soo Ding
Non-Executive Chairman1.5yrsAU$73.42k0.060%
A$ 4.6k
Christopher Ramsay
Non-Executive Director1.5yrsAU$6.97k0.059%
A$ 4.5k
Chris Ramsey
Non Executive Director1.2yrsAU$52.00k0.059%
A$ 4.5k

1.6yrs

Average Tenure

Experienced Board: BGT's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.